Last updated: April 2026
MedVi vs Peter MD: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and Peter MD: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and Peter MD are two established telehealth providers offering GLP-1–based weight‑management programs. This article compares MedVi vs Peter MD to help you identify which best fits your goals and preferences.
MedVi vs Peter MD: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month | — No |
| Peter MD | — |
MedVi vs Peter MD: Medical Process & Accessibility
MedVi emphasizes a rapid telehealth intake. After you complete a secure online questionnaire, a board‑certified physician reviews your health history, confirms eligibility, and issues a prescription within 24‑48 hours when appropriate. The medication is then shipped from a U.S. compounding pharmacy directly to your door.
Peter MD follows a slightly longer onboarding sequence that includes a video consult, optional lab work, and a personalized treatment plan. Follow‑up appointments are scheduled every 4‑6 weeks to assess response, adjust dosing, and address side‑effects. Like MedVi, all interactions are fully virtual and prescriptions are dispensed by a licensed U.S. pharmacy.
MedVi vs Peter MD: Pricing Comparison
MedVi starts semaglutide at $179.00 per month and tirzepatide at $279.00 per month. The first month includes a $120 discount, effectively reducing the initial out‑of‑pocket cost to $59 for semaglutide or $159 for tirzepatide. There are no mandatory membership fees, and you may discontinue at any time without penalty.
Peter MD does not publicly list specific medication prices on its landing page, opting instead for a customized quote after the initial consult. Because of this, a direct price‑to‑price comparison is not possible at this time. Prospective patients should inquire about any promotional discounts or membership structures during the intake call.
MedVi vs Peter MD: Clinical Oversight & Support
Both platforms employ U.S.-licensed physicians, nurse practitioners, or physician assistants who are authorized to prescribe GLP‑1 agonists. After the initial prescription, each provider offers ongoing support via secure messaging, phone, or video. MedVi’s support team is geared toward quick answer turnaround, whereas Peter MD provides a dedicated care coordinator who tracks progress and proactively reaches out for dose titration.
Book a Consultation with MedVi
All clinical decisions comply with FDA regulations for compounded medications, and both companies stress that GLP‑1 therapy must be used under direct medical supervision. Neither platform dispenses medication without a qualified prescriber’s order.
Schedule a Clinical Review with Peter MD
MedVi vs Peter MD: Medication Quality & Safety
The GLP‑1 products offered by MedVi and Peter MD are compounded formulations of semaglutide or tirzepatide, prepared in FDA‑registered compounding pharmacies. While they are not the brand‑name products Wegovy® or Mounjaro®, they contain the same active ingredients in clinically validated concentrations. Both providers adhere to Good Manufacturing Practices (GMP) and provide a Certificate of Analysis with each shipment.
Patients are reminded that all GLP‑1 therapies carry potential side effects, including nausea, vomiting, and rare cases of pancreatitis. Providers require a thorough medical history and, when indicated, baseline lab work to ensure safety before initiating treatment.
MedVi vs Peter MD: Customer Experience
Online reviews indicate that MedVi users appreciate the straightforward pricing model, rapid prescription approval, and discreet packaging. Some note that the lack of a scheduled follow‑up can feel less personalized, though the platform does allow patients to request additional visits as needed.
Peter MD’s clientele frequently highlight the comprehensive care pathway, regular check‑ins, and a more hands‑on approach to dose adjustments. The trade‑off can be a longer waiting period for the first prescription, but many feel the extra clinician interaction justifies the timeline.
MedVi vs Peter MD: Final Verdict
If you prioritize low upfront cost, fast onboarding, and a simple, no‑membership structure, MedVi is a strong choice. The $120 first‑month discount and transparent monthly pricing make budgeting straightforward.
If you value a more intensive clinical relationship, scheduled follow‑ups, and a customized pricing plan based on your individual health profile, Peter MD may align better with your expectations.
Both providers operate under U.S. telehealth regulations, require a licensed prescriber’s authorization, and ship only to addresses within the United States. Ultimately, the right program depends on your comfort with the level of medical oversight and your personal budget.
Join MedVi
Get Started with Peter MD
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Recommended next step
Review the latest provider details before you decide.